BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6163323)

  • 1. 32P-pyrophosphate in the treatment of persistent metastatic bone pain.
    Werner B; Isacson C; Lundell G; Lönnbeck C; Söderborg B
    Acta Radiol Oncol; 1980; 19(5):327-9. PubMed ID: 6163323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.
    Cheung A; Driedger AA
    Radiology; 1980 Jan; 134(1):209-12. PubMed ID: 6153129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic curietherapy with P-32 in bone metastases in breast cancer].
    Navarro-Izquierdo AL; Baringo T; Domínguez J; Duque JJ; Martínez Comín L; Solsona F
    Rev Esp Oncol; 1980; 27(1):101-6. PubMed ID: 6163183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
    Flamm J; Burkert S
    Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective and economical option for pain palliation in prostate cancer with skeletal metastases: 32P therapy revisited.
    Shah Syed GM; Maken RN; Muzzaffar N; Shah MA; Rana F
    Nucl Med Commun; 1999 Aug; 20(8):697-702. PubMed ID: 10451877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of painful osseous metastases with phosphorus-32-labeled phosphates.
    Silberstein EB
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):10-21. PubMed ID: 7684860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 32P therapy and sequential hemibody irradiation (HBI) for bony metastases as methods of whole body irradiation.
    Aziz H; Choi K; Sohn C; Yaes R; Rotman M
    Am J Clin Oncol; 1986 Jun; 9(3):264-8. PubMed ID: 2425617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiopharmaceuticals in clinical trials.
    Holmes RA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiophosphorous (P32) treatment in carcinoma of the breast and prostate: report of 39 cases.
    Miller AD
    J Am Osteopath Assoc; 1974 Nov; 74(3):217-22. PubMed ID: 4139177
    [No Abstract]   [Full Text] [Related]  

  • 11. [Palliative radiophosphorus therapy for analgesia in bone metastases].
    Grossmann J; Deckart H; Weiss M
    Radiobiol Radiother (Berl); 1988; 29(6):735-6. PubMed ID: 2473483
    [No Abstract]   [Full Text] [Related]  

  • 12. Does renal damage occur after the administration of 32P for palliation of pain from skeletal metastases?
    Nair N; Mahadeo DS; Patel R
    Nucl Med Commun; 1998 Jul; 19(7):689-93. PubMed ID: 9853350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
    Krishnamurthy GT; Krishnamurthy S
    J Nucl Med; 2000 Apr; 41(4):688-91. PubMed ID: 10768570
    [No Abstract]   [Full Text] [Related]  

  • 14. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
    Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
    J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 32P-sodium phosphate treatment of metastatic malignant disease.
    Roberts DJ
    Clin Nucl Med; 1979 Mar; 4(3):92-3. PubMed ID: 428168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the prostate: the treatment of bone metastases by radioactive phosphorus (32P).
    Ariel IM; Hassouna H
    Int Surg; 1985; 70(1):63-6. PubMed ID: 4019087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [32P] diphosphonate dose determination in patients with bone metastases from prostatic carcinoma.
    Potsaid MS; Irwin RJ; Castronovo FP; Prout GR; Harvey WJ; Francis MD; Tofe AJ; Zamenhof RG
    J Nucl Med; 1978 Jan; 19(1):98-104. PubMed ID: 413889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of distant iodine-negative metastases of thyroid cancer with 32P].
    Drozdovskiĭ BI; Proshin VV
    Vopr Onkol; 1996; 42(3):71-2. PubMed ID: 8801747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer therapy using bone-seeking isotopes.
    Lewington VJ
    Phys Med Biol; 1996 Oct; 41(10):2027-42. PubMed ID: 8912378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective.
    Montebello JF; Hartson-Eaton M
    Cancer Invest; 1989; 7(2):139-60. PubMed ID: 2477119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.